Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Mallinckrodt, Endo merge in US$ 6.7 bn deal; Astra buys cell therapy developer EsoBiotec; Pfizer sells entire stake in Haleon

In Phispers this week, two drugmakers emerging from bankruptcy — Mallinckrodt and Endo — are merging in order to le...

Impressions : 694

Roche buys rights to Zealand's obesity med in US$ 5.3 bn deal; Merck wins Gardasil lawsuit, bolsters vaccine manufacturing

In news this week, Roche has acquired rights to develop and commercialize Zealand Pharma’s experimental obesity drug petr...

Impressions : 1049

AbbVie enters obesity race with US$ 2.23 bn deal with Denmark's Gubra; Roche's TNKase approved for treating strokes

AbbVie has forayed into the obesity treatment market with a US$ 2.23 billion licensing deal with Denmark’s Gubra for its ...

Impressions : 797

Lilly to invest US$ 27 bn in US as Trump threatens big pharma with tariffs; FDA scrambles to rehire after mass layoffs

In the US, President Donald Trump has been putting pressure on Big Pharma to reshore or face tariffs. Eli Lilly has been the ...

Impressions : 920

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Mallinckrodt, Endo merge in US$ 6.7 bn deal; Astra buys cell therapy developer EsoBiotec; Pfizer sells entire stake in Haleon

Roche buys rights to Zealand's obesity med in US$ 5.3 bn deal; Merck wins Gardasil lawsuit, bolsters vaccine manufacturing

AbbVie enters obesity race with US$ 2.23 bn deal with Denmark's Gubra; Roche's TNKase approved for treating strokes

Lilly to invest US$ 27 bn in US as Trump threatens big pharma with tariffs; FDA scrambles to rehire after mass layoffs

Merck's Biologic Keytruda Receives Approval in US

Biogen's Biologic Tysabri Receives Suppl Approval in US

Sandoz's Biologic Imuldosa Receives Suppl Approval in US

Taro's Generics Rivaroxaban Receives Tentative Approval in US

Taro's Generics Rivaroxaban Receives Approval in US

Lupin's Generics Rivaroxaban Receives Approval in US

Lupin's Generics Rivaroxaban Receives Tentative Approval in US

Gland Pharma's Generics Lofexidine HCl Receives Approval in US

MSN's Generics Posaconazole Receives Approval in US

MSN's Generics Lofexidine HCl Receives Approval in US

Enforcement Report - Week of March 5, 2025

Granules India Receives FDA Warning Letter

Chem-Tech Receives FDA Warning Letter

TKTX Numbing Cream Receives FDA Warning Letter

One Source Nutrition Issues Nationwide Recall of Vitality

FDA Issues Form 483 to Glenmark Pharmaceuticals

Enforcement Report - Week of February 26, 2025

Enforcement Report - Week of February 19, 2025

ICU Medical recalls potassium chloride IV bags over labeling snafu

Jagsonpal Pharma Receives FDA Warning Letter

Biodexa on track to start funded Phase 3 trial in FAP soon

TwoStep Therapeutics Reveals Lead Tumor Drug at Debut Presentation

Immunovant Announces Positive Results for MG and CIDP Studies

Servier Nabs Tumor Asset in up to $780M Deal With Black Diamond

Novartis' Intrathecal Zolgensma Effective in Older Children

Novartis & Roche ditch some diversity programmes on US concerns

Eli launches Mounjaro in India after drug regulator approval

Sanofi to acquire Dren Bio's immunology unit

Advanced Instruments to Acquire and Merge with Nova Biomedical

Interactive Strength Updates Shareholders On Growth

MAIA Bio gets USAN Approval for "Ateganosine" as Anticancer Agent

Nexus Pharmaceuticals Launches Tranexamic Acid

Alkem launches generic empagliflozin & combinations in India

Glenmark Pharma launches Empagliflozin and combinations in India

Alkem Launches Empagliflozin, Fixed Combos In India As Empanorm

Zentiva Challenges Wastewater Directive To Protect Access

$275 Million Settlement Benefits Consumers in Generic Drug Case

Sunshine Bio Acquires Rights to Launch 2 Gastrointestinal Drugs

AstraZeneca approved to sell hyperkalaemia treatment in India

Curia Announces Strategic Refinancing to Support Continued Growth

Immunovant Announces Positive Results for MG and CIDP Studies

Novartis' Intrathecal Zolgensma Effective in Older Children

Sanofi to acquire Dren Bio's immunology unit

Sobi Collaborates On Gamifant In Sepsis At ISICEM Congress

CollPlant Biotech sets date for 2024 Q4 & financial Result

Regenxbio Reports Positive Biomarker Data from Duchenne Trial

Porton Advanced partners with Eureka Therapeutics for TCell Therapy

Cellares, Cabaletta Bio Complete Rese-cel Manufacturing Program

Precision BioSciences Presents Preclinical Data on PBGENE-DMD

Satellos Presents Initial Data From SAT-3247 Trial

Shilpa Wins SEC-CDSCO Nod For Nor-Ursodeoxycholic Acid In NASH

LGM Pharma Invests $6M in U.S. Drug Manufacturing Capabilities

The Noramco Invests $25M into Halo Pharma Facility in NJ

Axplora Launches Payload Manufacturing Workshop in France

HighByte Launches API Builder for Industrial Data

Senores Pharma begins operations at greenfield API facility

Veeva Adds Direct Data API to Veeva Vault Platform

Florricks Lifecare Expands With $95M Investment in EU, HK

Publication in the scientific journal Biomedical Chromatography

Chongqing Sintaho s Peptide API Plant Upgrade Gets Review

ProDentim Warns of Fake Listings in Growing Supplement Market

AquaSculpt targets unauthorized sellers amid counterfeit surge

US FDA warns against recreational use of 'laughing gas'

Nectar Gets 7 Observations From EDQM For API Facility

Symbiosis Completes FDA Regulatory Inspection For Gene Therapy

Shilpa Medicare's Raichur Unit Gets USFDA 483 With One Issue

USFDA Issues Form 483 With 3 Observations To Gland Pharma

Alembic Pharma's Vadodara Facility Gets One USFDA 483

Indoco Remedies Falls As Hyderabad Facility Gets USFDA 483

Glenmark recalls 1.5M bottles of ADHD drug due to impurities

ESSE Care Launches Year-Long Initiative for Endometriosis

UniDoc Buys AGNES Connect Software from AMD Telemedicine

Cortland Expands Braiding Tech For Medical Devices